
Prudentia brings together expert-developed frameworks, AI trained on drug development, and a unified evidence base to produce outputs grounded in science and ready for decision-making.
Unify fragmented data sources into a single, connected evidence base
Apply expert-developed frameworks to evaluate assets consistently
Scale scientific reasoning across deals
Deep expertise across drug development, clinical strategy, and deal execution. This experience shapes the scientific frameworks behind every Prudentia evaluation.
Meet the teamMeet the team$0B+
Deal value across team experience
0+
Assets evaluated
0+
Drugs brought to market including Keytruda, Celebrex, Chimera, and more
Life sciences dealmaking involves some of the most sensitive data in the industry. Prudentia operates as the connective intelligence layer between pharma, biotech, VDR, and deal team, with every role bounded and every handoff disclosed.
Visit our Trust CenterVisit our Trust CenterSingle-tenant deployment with your data siloed and never shared across customers
SSO integration with granular access controls and permissions
Encryption at rest and in transit, with complete audit trails
Your data is never used to train models, aligned with ISO/IEC 42001:2023
Deals move faster when every party at the table is working from the same protected evidence.
Evaluate more assets with greater consistency. Apply expert diligence frameworks at scale, with AI reasoning grounded in scientific evidence and full data provenance across every deal.
I’m in pharmaMake your asset legible to the buyers who matter. Profile, benchmark, and position using the same evaluation lens pharma BD applies, then share on your terms with verified counterparties.
I’m at a biotechMove transactions forward with confidence. From scientific staging and buyer matching to NDA management, diligence coordination, and term sheet support.